Publisher Correction: Harnessing innate immunity in cancer therapy

Article metrics

Correction to: Nature online 2 October 2019

In this Review, owing to an error during the production process, an incorrect version of Supplementary Table 1 was published. This has now been updated, and for transparency to readers the original Supplementary Table 1 is provided as Supplementary Information to this Amendment. Additionally, there were errors in the citations in the paragraph beginning ‘The interplay between innate and adaptive immunity…’. These have been amended and references 11–13 have been renumbered in the reference list accordingly. The original reference 11 (Scheper et al., Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89–94 (2019)) is no longer cited in the Review, and reference 13 (Crozat et al., 2010) has been added and is cited in the above paragraph. The original Review has been corrected online.

Supplementary Information is available in the online version of this Amendment.

Author information

Correspondence to Eric Vivier.

Supplementary information

Supplementary Table 1

This file contains the uncorrected version of Supplementary Table 1.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Demaria, O., Cornen, S., Daëron, M. et al. Publisher Correction: Harnessing innate immunity in cancer therapy. Nature 576, E3 (2019) doi:10.1038/s41586-019-1758-2

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.